“Our industry is constantly faced with new and unique challenges, but through CRN and its member companies, we are more than equipped to tackle them,” said Kamil. “The recent efforts by CRN in helping pass the Designer Anabolic Steroid Control Act (DASCA) of 2014 showed the strength of our industry when we mobilize and our ability to get legislation passed even in today’s political environment.
“Moving forward, we’ll continue to educate the 114th Congress on the benefits of dietary supplements and the regulations that responsible companies follow; we’ll strongly urge FDA and FTC to enforce the current law but not overstep boundaries; and we’ll continue to be the leading advocates on behalf of our member companies to promote the continued long-term, sustainable growth of our industry.”
CRN’s Board has also approved new Board officers to serve alongside Mr. Kamil during his two-year term: Chair-Elect—Tyler Whitehead, Nu Skin Enterprises, Inc.; Treasurer—Marjorie Fine, Shaklee Corporation; Secretary—Jim Hyde, Albion Laboratories, Inc.; and Immediate Past Chair—John Blair, The Juice Plus+ Company. Steve Mister, CRN President & CEO, will continue to serve as a Board Officer.
CRN’s membership elected two new Board Directors: Jeremy Moore, Stratum Nutrition; and Kevin Salerno, HORN Nutraceuticals. In addition, Michael DeGennaro, Lonza Inc., and Jim Hyde, Albion Laboratories, Inc., were re-elected for a second three-year term, and Jim Hamilton, Neptune Technologies & Bioressources Inc., was appointed by the Board Chairman to serve a one-year term.
Please click HERE for a complete list of CRN’s Board of Directors.